T1	Participants 13 53	adults with acute lymphoblastic leukemia
T2	Participants 175 221	adults with acute lymphoblastic leukemia (ALL)
T3	Participants 772 828	patients with Philadelphia chromosome (Ph)-positive ALL.
T4	Participants 1096 1145	accrued patients from August 1996 to October 2004
T5	Participants 1272 1284	164 patients
